ECSP11011354A - Composiciones óticas útiles para el tratamiento de infecciones del oído interno y externo en maíferos - Google Patents

Composiciones óticas útiles para el tratamiento de infecciones del oído interno y externo en maíferos

Info

Publication number
ECSP11011354A
ECSP11011354A EC2011011354A ECSP11011354A ECSP11011354A EC SP11011354 A ECSP11011354 A EC SP11011354A EC 2011011354 A EC2011011354 A EC 2011011354A EC SP11011354 A ECSP11011354 A EC SP11011354A EC SP11011354 A ECSP11011354 A EC SP11011354A
Authority
EC
Ecuador
Prior art keywords
treatment
maíferos
internal
external ear
ear infections
Prior art date
Application number
EC2011011354A
Other languages
English (en)
Inventor
Bo Liang
Joseph A Capriotti
C Michael Samson
Jason Stein
Michael Weiser
Original Assignee
Foresight Biotherapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44834943&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ECSP11011354(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Foresight Biotherapeutics Inc filed Critical Foresight Biotherapeutics Inc
Publication of ECSP11011354A publication Critical patent/ECSP11011354A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A61K31/79—Polymers of vinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0046—Ear
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Composiciones que incluyen povidona yodada (PVP-I) útil en el tratamiento de infecciones bacterianas, virales y fungales, de tipo crónico o agudo en el oído interno, medio y externo de mamíferos, incluyendo humanos.
EC2011011354A 2009-02-27 2011-09-26 Composiciones óticas útiles para el tratamiento de infecciones del oído interno y externo en maíferos ECSP11011354A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12/380,463 US20090263345A1 (en) 2008-01-28 2009-02-27 Otic compositions for the treatment of infections of the internal and external ear in mammals

Publications (1)

Publication Number Publication Date
ECSP11011354A true ECSP11011354A (es) 2011-12-30

Family

ID=44834943

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2011011354A ECSP11011354A (es) 2009-02-27 2011-09-26 Composiciones óticas útiles para el tratamiento de infecciones del oído interno y externo en maíferos

Country Status (15)

Country Link
US (3) US20090263345A1 (es)
EP (2) EP3673736A1 (es)
JP (3) JP5714512B2 (es)
KR (4) KR20110133479A (es)
CN (2) CN102333444A (es)
AU (3) AU2010218108B2 (es)
BR (1) BRPI1012230A2 (es)
CA (1) CA2753964C (es)
CL (1) CL2011002091A1 (es)
CO (1) CO6450663A2 (es)
EC (1) ECSP11011354A (es)
MX (1) MX2011008920A (es)
NZ (1) NZ594884A (es)
PE (2) PE20151298A1 (es)
WO (1) WO2010099212A1 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7767217B2 (en) 2006-03-14 2010-08-03 Foresight Biotherapeutics Ophthalmic compositions comprising povidone-iodine
AU2015252097A1 (en) * 2009-12-15 2015-11-19 Foresight Biotherapeutics, Inc. Non-irritating ophthalmic povidone-iodine compositions
TWI620569B (zh) * 2009-12-15 2018-04-11 遠景生物製藥股份有限公司 無刺激性眼用聚乙烯吡咯啶酮-碘組成物
EP2707007B1 (en) * 2011-05-11 2018-03-07 Veloce BioPharma LLC Antifungal compositions for the treatment of nails
US20170071979A1 (en) * 2011-05-11 2017-03-16 Veloce Biopharma, Llc Composition and method for treating otitis
WO2012177251A1 (en) * 2011-06-22 2012-12-27 Adeda Therapeutics Company Limited Pharmaceutical compositions comprising iodine and steroid and uses thereof for sinus diseases
TW201808311A (zh) * 2011-09-16 2018-03-16 遠景生物製藥股份有限公司 安定之普維酮-碘組成物
CN102429862B (zh) 2011-11-29 2013-05-01 江苏德达医药科技有限公司 一种聚维酮碘眼用缓释滴眼液
CN102988424A (zh) * 2012-12-29 2013-03-27 潍坊富邦药业有限公司 一种加速动物伤口愈合、止痛生肌的喷雾剂及制备工艺
CN105120875B (zh) * 2013-02-15 2018-01-09 千寿制药株式会社 包含锌的二氟泼尼酯乳液组合物
DE102014000132A1 (de) * 2014-01-13 2015-07-16 Marco Bergmann Verfahren und Vorrichtung zum Anordnen mehrerer Lebensmittel in wenigstens einem Unterteil einer Verpackung
KR20180011882A (ko) 2015-01-20 2018-02-02 벨로체 바이오파르마 엘엘씨 신규한 요오드포 조성물 및 사용 방법
EP3495930A1 (en) * 2015-04-24 2019-06-12 LG Innotek Co., Ltd. Touch window
JP6255134B1 (ja) * 2016-11-02 2017-12-27 ヴェローチェ・バイオファーマ・エルエルシー 耳炎の治療のための組成物および方法
EP3512522B1 (en) * 2017-09-02 2025-11-12 IVIEW Therapeutics, Inc. In situ gel-forming pharmaceutical compositions and uses thereof for sinus diseases
JP2022151438A (ja) * 2021-03-26 2022-10-07 均 石井 外耳炎と中耳炎と内耳炎の治療薬。
WO2025144407A1 (en) * 2023-12-28 2025-07-03 Iview Therapeutics, Inc. Methods for increasing stability of dilute povidone iodine

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0878197B1 (en) * 1997-05-14 2002-08-21 Senju Pharmaceutical Co., Ltd. Compositions containing difluprednate
US20030139382A1 (en) * 2001-09-21 2003-07-24 Alcon, Inc. Method of treating middle ear infections
WO2004052236A2 (en) * 2002-12-06 2004-06-24 Arriva Pharmaceuticals, Inc. Methods and compositions for treatment of otitis media
US20060057226A1 (en) * 2004-09-16 2006-03-16 Johnson John M Red ear drops
TW200719884A (en) * 2005-03-10 2007-06-01 3M Innovative Properties Co Methods of treating ear infections
US20060280809A1 (en) * 2005-06-14 2006-12-14 Leshchiner Adele K Anti-infective iodine based compositions for otic and nasal use
US7767217B2 (en) * 2006-03-14 2010-08-03 Foresight Biotherapeutics Ophthalmic compositions comprising povidone-iodine
US20080167281A1 (en) * 2007-01-05 2008-07-10 Preston David M Combination Otic Formulation
US20080172032A1 (en) * 2007-01-11 2008-07-17 James Pitzer Gills Method for preventing tissue damage associated with irrigation of tissue with an antimicrobial solution
WO2008137658A1 (en) * 2007-05-03 2008-11-13 Mayo Foundation For Medical Education And Research Otitis externa
AU2009258145A1 (en) * 2008-06-12 2009-12-17 Foresight Biotherapeutics, Inc. Povidone iodine, a novel alternative preservative for ophthalmic compositions

Also Published As

Publication number Publication date
CL2011002091A1 (es) 2012-04-20
CN102333444A (zh) 2012-01-25
KR20160112024A (ko) 2016-09-27
US20120003174A1 (en) 2012-01-05
PE20120183A1 (es) 2012-03-15
BRPI1012230A2 (pt) 2017-11-07
US20090263345A1 (en) 2009-10-22
JP2015083589A (ja) 2015-04-30
AU2016203574A1 (en) 2016-06-16
KR20110133479A (ko) 2011-12-12
WO2010099212A1 (en) 2010-09-02
EP2400842A1 (en) 2012-01-04
EP2400842A4 (en) 2013-08-28
AU2017268575A1 (en) 2017-12-14
MX2011008920A (es) 2011-09-09
CA2753964C (en) 2019-03-12
US20130089510A1 (en) 2013-04-11
JP2012519175A (ja) 2012-08-23
CA2753964A1 (en) 2010-09-02
NZ594884A (en) 2014-02-28
KR20190100237A (ko) 2019-08-28
JP5714512B2 (ja) 2015-05-07
PE20151298A1 (es) 2015-10-10
CN105362286A (zh) 2016-03-02
EP3673736A1 (en) 2020-07-01
AU2016203574B2 (en) 2017-08-31
CO6450663A2 (es) 2012-05-31
AU2010218108A1 (en) 2011-10-20
JP2017031202A (ja) 2017-02-09
AU2010218108B2 (en) 2016-07-07
KR20180017213A (ko) 2018-02-20

Similar Documents

Publication Publication Date Title
CO6450663A2 (es) Composiciones óticas útiles para el tratamiento de infeciones del oído interno y externo en mamíferos
BR112017028413A2 (pt) peptídeos antimicrobianos estabilizados
HRP20180972T1 (hr) Kombinacija fenoksibenzamina i polimiksina e za liječenje mikrobnih infekcija
CL2013001316A1 (es) Composicion que comprende micro-organismo probioticos no replicantes que protegen contra las infecciones del tracto respiratorio superior.
IL213528A0 (en) Compositions and methods for the treatment of the prevention of staphylococcus aureus infections and for the eradication or reduction of staphylococcus aureus on surfaces
CL2016001524A1 (es) Derivados antibacterianos de 1h-indazol y 1h-indol.
CU20080044A7 (es) Composiciones farmacéuticas para el tratamiento de trastornos del oído interno.
DK3403669T3 (da) Fremgangsmåder til behandling og forebyggelse af staphylococcus aureus-infektioner og forbundne tilstande
MX2009008617A (es) Uso de antagonistas de interleucina-23 para el tratamiento de infeccion.
IL213489A0 (en) Compositions and methods for the treatment of the prevention of e. coli infections and for the eradication or reduction of e. coli surfaces
BRPI1010887A2 (pt) derivados de triazina e suas aplicações terapêuticas.
EP2563371A4 (en) ANTIBACTERIAL APPLICATIONS OF POLY-N-ACETYL GLUCOSAMINE NANO FIBERS
BR112015029367A2 (pt) terapia combinada compreendendo oxazolidinona-quinolonas para uso no tratamento de infecções bacterianas
LT3820856T (lt) C-manozido junginiai, naudingi šlapimo takų infekcijoms gydyti
CL2011000165A1 (es) Compuestos derivados de indolinonas; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento y/o la prevencion del cancer, infecciones, enfermedades inflamatorias y autoinmunes.
MX2017002385A (es) Metodos y reactivos para la prevencion y/o el tratamiento de infecciones.
CL2008002384A1 (es) Compuestos derivados de quinoliniloxipiperidina y pirrolidina, composicion farmaceutica, combinacion farmaceutica, util para el tratamiento de enfermedades inflamatorias y/o alergicas del tracto respiratorio.
MA47437A (fr) Procédés de traitement d'infections fongiques
EA201500913A1 (ru) Противомикробные соединения и способы их получения и применения
EP3655028A4 (en) COMPOSITIONS AND METHODS OF P. AERUGINOSA INFECTION
EP4398893A4 (en) IBOGAINE COMBINATION THERAPY
DK4312925T3 (da) Absorberende kompositter
ZA201808182B (en) Composition comprising at least one enzyme and at least one microbicidal molecule for the prevention or treatment of post-implant infections
EA201270547A1 (ru) Фармацевтическая композиция
EP4337181A4 (en) COMBINED TREATMENT PROCESSES